These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 10438663
1. Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures. Di Monte DA, Tokar I, Langston JW. Toxicol Appl Pharmacol; 1999 Aug 01; 158(3):296-302. PubMed ID: 10438663 [Abstract] [Full Text] [Related]
2. Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes. Wu EY, Langston JW, Di Monte DA. J Pharmacol Exp Ther; 1992 Jul 01; 262(1):225-30. PubMed ID: 1625201 [Abstract] [Full Text] [Related]
3. Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. Di Monte DA, Wu EY, Delanney LE, Irwin I, Langston JW. J Pharmacol Exp Ther; 1992 Apr 01; 261(1):44-9. PubMed ID: 1560384 [Abstract] [Full Text] [Related]
4. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes. Di Monte DA, Wu EY, Irwin I, Delanney LE, Langston JW. Glia; 1992 Apr 01; 5(1):48-55. PubMed ID: 1311704 [Abstract] [Full Text] [Related]
5. Edaravone protects against MPP+ -induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway. Chen H, Wang S, Ding JH, Hu G. J Neurochem; 2008 Sep 01; 106(6):2345-52. PubMed ID: 18643790 [Abstract] [Full Text] [Related]
6. Differences in the disposition and toxicity of 1-methyl-4-phenylpyridinium in cultured rat and mouse astrocytes. Tsai MJ, Lee EH. Glia; 1994 Dec 01; 12(4):329-35. PubMed ID: 7890335 [Abstract] [Full Text] [Related]
7. Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A. Wu JY, Niu FN, Huang R, Xu Y. Neuroreport; 2008 Aug 06; 19(12):1209-12. PubMed ID: 18628666 [Abstract] [Full Text] [Related]
8. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells. Mazzio EA, Soliman KF. Biochem Pharmacol; 2004 Mar 15; 67(6):1167-84. PubMed ID: 15006552 [Abstract] [Full Text] [Related]
9. Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes. Yao HH, Ding JH, Zhou F, Wang F, Hu LF, Sun T, Hu G. J Neurochem; 2005 Feb 15; 92(4):948-61. PubMed ID: 15686497 [Abstract] [Full Text] [Related]
11. MPP(+) causes inhibition of cellular energy supply in cerebellar granule cells. González-Polo RA, Soler G, Alonso JC, Rodríguez-Martín A, Fuentes JM. Neurotoxicology; 2003 Mar 15; 24(2):219-25. PubMed ID: 12606294 [Abstract] [Full Text] [Related]
12. MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport. Desai VG, Feuers RJ, Hart RW, Ali SF. Brain Res; 1996 Apr 09; 715(1-2):1-8. PubMed ID: 8739616 [Abstract] [Full Text] [Related]
13. Uncoupling of ATP-depletion and cell death in human dopaminergic neurons. Pöltl D, Schildknecht S, Karreman C, Leist M. Neurotoxicology; 2012 Aug 09; 33(4):769-79. PubMed ID: 22206971 [Abstract] [Full Text] [Related]
14. Glutamate uptake inhibitor L-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production. García O, Massieu L. J Neurosci Res; 2003 Dec 15; 74(6):956-66. PubMed ID: 14648602 [Abstract] [Full Text] [Related]
15. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Lannuzel A, Michel PP, Höglinger GU, Champy P, Jousset A, Medja F, Lombès A, Darios F, Gleye C, Laurens A, Hocquemiller R, Hirsch EC, Ruberg M. Neuroscience; 2003 Dec 15; 121(2):287-96. PubMed ID: 14521988 [Abstract] [Full Text] [Related]
16. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Matos M, Augusto E, Oliveira CR, Agostinho P. Neuroscience; 2008 Oct 28; 156(4):898-910. PubMed ID: 18790019 [Abstract] [Full Text] [Related]
17. The use of astrocytes in culture as model systems for evaluating neurotoxic-induced-injury. Aschner M, Kimelberg HK. Neurotoxicology; 1991 Oct 28; 12(3):505-17. PubMed ID: 1684034 [Abstract] [Full Text] [Related]
18. Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake. Lu M, Hu LF, Hu G, Bian JS. Free Radic Biol Med; 2008 Dec 15; 45(12):1705-13. PubMed ID: 18848879 [Abstract] [Full Text] [Related]
19. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza JC, Lorenzo P, Secades JJ, Lozano R, Dávalos A, Castillo J, Lizasoain I. Neurobiol Dis; 2005 Mar 15; 18(2):336-45. PubMed ID: 15686962 [Abstract] [Full Text] [Related]
20. Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Bal-Price A, Moneer Z, Brown GC. Glia; 2002 Dec 15; 40(3):312-23. PubMed ID: 12420311 [Abstract] [Full Text] [Related] Page: [Next] [New Search]